178 related articles for article (PubMed ID: 23531428)
1. [Micrometastasis: biological entity and clinical impact?].
Houvenaeghel G; Cohen M; Bannier M; Buttarelli M; Jauffret C; Lambaudie E
Bull Cancer; 2013 Apr; 100(4):351-6. PubMed ID: 23531428
[TBL] [Abstract][Full Text] [Related]
2. [Clinical significance of sentinel lymph node micrometastases in invasive breast carcinoma].
Tsugawa K
Nihon Geka Gakkai Zasshi; 2013 Jan; 114(1):22-7. PubMed ID: 23457941
[TBL] [Abstract][Full Text] [Related]
3. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
4. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases.
Meattini I; Giannotti E; Abdulcadir D; Saieva C; Guerrieri AM; Vanzi E; Scartoni D; Cecchini S; Sanchez LJ; Orzalesi L; Casella D; Bianchi S; Livi L; Nori J
Eur J Surg Oncol; 2014 Mar; 40(3):277-81. PubMed ID: 24388742
[TBL] [Abstract][Full Text] [Related]
5. [Regional treatment for axillary lymph node micrometastases of breast cancer].
Houvenaeghel G; Cohen M; Jauffret-Fara C; Bannier M; Chéreau-Ewald É; Rua Ribeiro S; Lambaudie É
Cancer Radiother; 2015 Jun; 19(4):276-83. PubMed ID: 26006761
[TBL] [Abstract][Full Text] [Related]
6. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
7. Axillary and systemic treatment of patients with breast cancer and micrometastatic disease or isolated tumor cells in the sentinel lymph node.
Maaskant-Braat AJ; Voogd AC; van de Poll-Franse LV; Coebergh JW; Nieuwenhuijzen GA
Breast; 2012 Aug; 21(4):524-8. PubMed ID: 22516371
[TBL] [Abstract][Full Text] [Related]
8. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph nodes with isolated tumour cells and micrometastases in breast cancer: clinical relevance and prognostic significance.
Ahmed SS; Thike AA; Iqbal J; Yong WS; Tan B; Madhukumar P; Ong KW; Ho GH; Wong CY; Tan PH
J Clin Pathol; 2014 Mar; 67(3):243-50. PubMed ID: 24218025
[TBL] [Abstract][Full Text] [Related]
10. Issues in breast cancer with minimal nodal involvement.
Rigatti SJ
J Insur Med; 2012; 43(1):18-26. PubMed ID: 22397127
[TBL] [Abstract][Full Text] [Related]
11. Pathologic Evaluation and Prognostic Implications of Nodal Micrometastases in Breast Cancer.
Dutta SW; Volaric A; Morgan JT; Chinn Z; Atkins KA; Janowski EM
Semin Radiat Oncol; 2019 Apr; 29(2):102-110. PubMed ID: 30827448
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of isolated tumor cells and micrometastases in axillary lymph nodes in breast cancer.
Madsen EV; Elias SG; van Dalen T; van Oort PM; van Gorp J; Gobardhan PD; Bongers V
Breast; 2013 Oct; 22(5):748-52. PubMed ID: 23313060
[TBL] [Abstract][Full Text] [Related]
13. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of occult metastases in axillary sentinel lymph nodes of breast carcinoma.
Amir AS; Azar FP; Sahram N; Naser FM; Na'ma MR; Farid F; Khatoon AN; Ramin S; Ali TK
Pol J Pathol; 2012 Mar; 63(1):40-4. PubMed ID: 22535605
[TBL] [Abstract][Full Text] [Related]
15. Risk of non-sentinel node metastases in patients with symptomatic cancers compared to screen-detected breast cancers.
Tvedskov TF; Jensen MB; Balslev E; Garne JP; Vejborg I; Christiansen P; Ejlertsen B; Kroman N
Acta Oncol; 2016; 55(4):455-9. PubMed ID: 26452696
[TBL] [Abstract][Full Text] [Related]
16. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases.
Nos C; Harding-MacKean C; Fréneaux P; Trie A; Falcou MC; Sastre-Garau X; Clough KB
Br J Surg; 2003 Nov; 90(11):1354-60. PubMed ID: 14598414
[TBL] [Abstract][Full Text] [Related]
17. The clinical significance of axillary lymph node micrometastases in breast cancer.
Sakorafas GH; Geraghty J; Pavlakis G
Eur J Surg Oncol; 2004 Oct; 30(8):807-16. PubMed ID: 15336724
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of breast cancer patients with micrometastases and isolated tumor cells in sentinel lymph nodes.
Gloyeske NC; Goreal W; O'Neil M; Connor C; Tawfik OW; Fan F
In Vivo; 2011; 25(6):997-1001. PubMed ID: 22021696
[TBL] [Abstract][Full Text] [Related]
19. [Adjuvant treatments in breast cancer: interest of completion of axillary dissection in case of micrometastases or isolated tumor cells in sentinel lymph node].
Schmitt C; Bouteille C; Faure C; Mignotte H; Tredan O; Bachelot T; Guastalla JP; Arnaud A; Treilleux I; Carrabin N
Bull Cancer; 2012 Apr; 99(4):463-9. PubMed ID: 22266799
[TBL] [Abstract][Full Text] [Related]
20. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
